ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 100 filers reported holding ATHIRA PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $762,944 | -49.5% | 377,695 | -26.3% | 0.00% | – |
| Q2 2023 | $1,512,128 | -24.2% | 512,586 | -35.7% | 0.00% | – |
| Q1 2023 | $1,993,646 | -39.3% | 797,458 | -23.1% | 0.00% | – |
| Q4 2022 | $3,285,924 | +22.7% | 1,036,569 | +15.0% | 0.00% | – |
| Q3 2022 | $2,677,000 | -54.8% | 901,281 | -53.6% | 0.00% | -100.0% |
| Q2 2022 | $5,923,000 | -67.5% | 1,941,787 | +43.8% | 0.00% | -50.0% |
| Q1 2022 | $18,233,000 | +35.5% | 1,350,587 | +30.8% | 0.00% | +33.3% |
| Q4 2021 | $13,452,000 | +16.2% | 1,032,437 | -16.3% | 0.00% | +50.0% |
| Q3 2021 | $11,575,000 | -13.5% | 1,233,949 | -5.5% | 0.00% | -33.3% |
| Q2 2021 | $13,377,000 | -42.4% | 1,306,406 | +3.4% | 0.00% | -50.0% |
| Q1 2021 | $23,240,000 | -41.6% | 1,263,070 | +8.8% | 0.01% | -40.0% |
| Q4 2020 | $39,770,000 | +99.8% | 1,161,158 | +7.7% | 0.01% | +66.7% |
| Q3 2020 | $19,900,000 | – | 1,078,015 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $351,351 | 0.48% |
| Perceptive Advisors | 4,797,278 | $14,632,000 | 0.46% |
| Ikarian Capital, LLC | 784,200 | $2,393,000 | 0.44% |
| Bristlecone Advisors, LLC | 700,926 | $2,138,000 | 0.26% |
| Altium Capital Management LP | 200,100 | $610,000 | 0.24% |
| RA Capital Management | 1,878,000 | $5,728,000 | 0.15% |
| Logos Global Management LP | 220,000 | $671,000 | 0.12% |
| PATHSTONE FAMILY OFFICE, LLC | 1,688,840 | $5,150,963 | 0.11% |
| Ikarian Capital, LLC | 199,500 | $609,000 | 0.11% |
| SG3 Management, LLC | 206,000 | $628,000 | 0.07% |